{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bfv1.1","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Limited","contributions":[{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bf_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10003","date":"2019-09-13T16:00:00.000Z","role":"Approver"},{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bf_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10003","date":"2020-10-12T17:43:07.505Z","role":"Publisher"}],"evidence":[{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bf_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bf_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bf_ad_other_el","type":"EvidenceLine","evidence":[{"id":"cggv:ceea750f-f42b-48d3-9703-6bb59c8ef49f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:e5b34878-9f71-4499-af4d-d0d1b9a78a5c","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":36,"detectionMethod":"","firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"Screening for Desmosomal genes and TMEM43-PLN-SCN5A variants","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:ceea750f-f42b-48d3-9703-6bb59c8ef49f_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:0c24fe95-6681-46b5-b95e-5db1974ce435","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000258.2(MYL3):c.461G>A (p.Arg154His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA013861"}},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29709087","type":"dc:BibliographicResource","dc:abstract":"Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by ventricular arrhythmias and sudden death. Currently 60% of patients meeting Task Force Criteria (TFC) have an identifiable mutation in one of the desmosomal genes. As much overlap is described between other cardiomyopathies and ARVC, we examined the prevalence of rare, possibly pathogenic sarcomere variants in the ARVC population.","dc:creator":"Murray B","dc:date":"2018","dc:title":"Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29709087","rdfs:label":"6"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25,"dc:description":"No segregation data"}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.25}],"evidenceStrength":"Limited","sequence":1325,"specifiedBy":"GeneValidityCriteria7","strengthScore":0.25,"subject":{"id":"cggv:b34ded29-f1d5-4cca-a84a-0140b2460ef7","type":"GeneValidityProposition","disease":"obo:MONDO_0016587","gene":"hgnc:7584","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","dc:description":"There is limited evidence that MYL3 is associated with ARVC.\nScreening of ARVC patient cohorts for MYL3 mutations has been performed in two studies (29709087, 22421524).\nIn first study (29709087) 137 ARVC patients were investigated for putative pathogenic variants. A missense variant causing the aminoacid substitution Arg154His was identified in one patient. This previously report variant is classified as likely pathogenic according to current ACMG criteria and has been demonstrate in vitro to disturb the binding of this protein to myosin. However, this variant has not been linked to ARVC phenotype and no segregation data were available.\nIn the second study (22421524) 14 ARVC patients were investigated but no MYL3 variants were reported.\nThere is no clear evidence that the identified MYL3 contribute to the ARVC phenotype and there is no known disease mechanism that would link MYL3 with ARVC.\n","dc:isVersionOf":{"id":"cggv:b1d5e9bf-ca57-445a-a432-27fe221484bf"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}